Autopsy report · NCT02186912
All-On-4® Treatment Concept
Cause of deathSlow enrollment
“The study stopped as the performance of the study showed insufficient patient recruitment.”
Life of this trial
- Registered 6 months after it had already started.
- Ran for about 1 year 11 months before it stopped.
- 28 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Nobel Biocare
- Sponsor type
- Industry
- Conditions
- Edentulous
- Interventions
- Nobel Active, Nobel Procera IBO
- Participants
- 28
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
“Study stopped due to difficulties in patient recruitment” - Dose-finding Study of MCI-196
“This study has been terminated because of insufficient patient recruitment.” - Comparing Palliative Radiotherapy With or Without Carboplatin
“The study was stopped due to insufficient recruitment.” - Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
“Study was stopped due to insufficient recruitment.” - Surgery Induced Trauma After Total Versus Medial Unicompartmental Knee Arthroplasty (SITA)
“The study was terminated due to poor participant accrual. Recruitment was limited by competing clinical studies at the participating site, and the resources required to prolong the recruitment period were not available.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.